Psychedelic Business Spotlight – February 25
This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon; Small Pharma advances DMT.
Greg Gilman is Psychedelic Spotlight's lead content editor, as well as a contributor. His previous work has appeared in dozens of publications, including USA Today, Yahoo! News, TheWrap, MovieMaker Magazine and SyFy Wire. When he's not writing, he's the lead singer for LA-based Americana rock band Greg in Good Company. Given his experience as an artist, he's particularly interested in the intersection of psychedelics and entertainment.
This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon; Small Pharma advances DMT.
Another study concludes with results challenging the increasingly popular narrative that microdosing psychedelics improves mood and cognitive function.
With no strong resistance manifesting to oppose the psychedelic renaissance, it appears these drugs have re-emerged from underground for a permanent place in our culture.
This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to MAPS; Cathie Wood eyes more psychedelic stocks.
Biotech companies and researchers opposed to five more tryptamines becoming schedule 1 controlled substances will present their case this spring.
“I don’t even know what got into my emotions, but I felt so good, and the crying just made me feel even better,” the Super Bowl halftime show performer says.
Levitee Labs Announces Interim CEO and Board of Directors Shuffle This week in psychedelic business news, Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7), a psychedelic medicine and wellness company, has appointed Philip van den Berg as Chief Executive Officer and to the Board of Directors, replacing Pouya Farmand, who will be moving to […]
This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one of the biggest gets bigger.
Difficult trips could be a problem in areas where psychedelics have been decriminalized, which is why MAPS will offer a psychonaut training program.
Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.